Sign Up For Live
Surfing The NASH Tsunami Podcast now includes Live Audience attendance during recordings. We record Monday afternoons EST, with invites sent out on Fridays. Our host Roger Green will invite you into the epsiode to ask your questions and to address your feedback regarding anything and everything in Fatty Liver Disease. Our usual Surfers will also be there too… each week… every episode!

43.2 2020 Year In Review: Emergence of Non-Invasive Tests and Testing Strategies in Fatty Liver Disease

Mazen Noureddin describes a year in which biopsy's shortcomings are revealed at the same time as non-invasive testing becomes better and produces more robust data

Mazen Noureddin discusses the simultaneous loss of faith in biopsy as the clinical “Gold Standard” and the emergence of non-invasive tests that can become the standard and replace biopsy for three pivotal diagnostic needs:

1. Identifying patients at risk, those with fibrosis levels equal to or higher than F2
2. Identifying patients who can serve as targets for clinical trial, which usually means they have NASH levels or at least N4 along with fibrosis greater than or equal to F2
3. Monitoring therapeutic responsiveness in both sets of patients over time without the need for serial biopsy.

Learn more about Mazen Noureddin

Request Transcript of This Episode
Request Transcript

Stay In Touch with Surfing NASH

Stay In Touch
  • Name
  • Email & NPI
  • Country
  • Institution & Profession